Advocates of quickly ending the shutdowns are in the news. Mostly, because one of them is President. Like most Americans, I think reopening soon would be a mistake (and remember I am in Italy where the shut down is severe compared to any State in the USA). I’m just going to assume that reopening by […]
Coronavirus dashboard for April 20: a few positive development Here is the update through yesterday (April 19) As usual, significant developments are in italics. Yesterday saw the biggest number of daily tests, and ratio of total vs. positive tests so far, both positive developments. The number and rate of daily infections and deaths also declined, but […]
This note was published on April 17, 2020, at NEJM.org. As a chief physician executive, I rarely get involved in my health system’s supply-chain activities. The Covid-19 pandemic has changed that. Protecting our caregivers is essential so that these talented professionals can safely provide compassionate care to our patients. Yet we continue to be stymied by […]
I want to try to punch above my weight (and be a troll) and contest this Dr. Kathryn Hibbert, director of the medical intensive care unit at Massachusetts General Hospital … said it will take weeks or months to get results and doctors and patients will need to wait for the results of the clinical […]
Abbreviated coronavirus dashboard for April 18 Here is the update through yesterday (April 17) There are some extended comments I want to make about the pandemic, and some graphs comparing States, etc., that are best done separately, so this will be an abbreviated update. Here are yesterday’s numbers. Number and rate of increase of Reported […]
Reposted from Brad DeLong’s Grasping Reality: What is the Real Prevalence of Coronavirus Across States? Click on the image to enlarge Tests per million times cases per test gives you confirmed cases per million. But we want true cases per million. Tests per million are different across states because (a) the states are undertaking testing with different […]
I want to think about how two pieces of news should change my thinking about COVID-19. (Warning: I have no expertise in medicine or public health, and you have no reason to take my thoughts seriously – but you knew that already.) A new serological study in Santa Clara county (discussed by Kevin Drum here) […]
Only two because the FDA did play an important role in the US Covid 19 testing fiasco. the first cheer is for extreme speed in approving phase 1 trials of candidate vaccines (vaccine in a person within 2 months of publication of the Sars Cov2 sequence) and phase III trials of Remdesivir (results leaking already) […]
The action sure isn’t over. The armies are still on the field, but I fear the outcome is no longer in doubt and hydroxychloroquine will lose this battle. There are two good studies which show almost exactly no benefit of hydroxychloroquine. They are reveiewed here. Basically the only benefit detected is as a nonspecific anti-inflamatory. […]
I have repeatedly argued that, based on in vitro evidence, hydroxychloroquine should be prescribed while we wait for the results of clinical trials. Such results were just published. They are very disappointing. The link is to an LA Times Article: latimes.com 2020-04-17 malaria-drugs-fails-to-help-coronavirus-patients-in-controlled-studies On the other hand Early peek at data on Gilead coronavirus drug […]